GluSense Company

GluSense is developing a miniature implantable continuous glucose sensor. The sensor will be implanted under the skin and will transmit continuous glucose values to an external unit or smartphone for over a full year, significantly improving the quality of life of diabetes patients. Founded in 2007, the company is part of the rainbow medical innovation house.

Investors

Technology: Diabetes, Health Care, Medical Device
Industry: Preventive Medicine
Headquarters: Lod, HaMerkaz, Israel
Founded Date: 2007
Employees Number: 10-50
Funding Status: N/A

Visit Website
boaz.brill@glusensemedical.com
Register and Claim Ownership